Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma

Pathology - Research and Practice(2021)10.1016/j.prp.2021.153382Source: DataRank Database

Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma is a research paper published in Pathology - Research and Practice (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

10 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.28)OA: closedTopics (47)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (0/2)

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Benjamin D. Korman ORCID,Edwin R. Parra ORCID,Ana Paula Pereira Velosa ORCID,Hermes Vieira Barbeiro,Vanessa Martins ORCID

Live enrichment

PubMed:33647866 OpenAlex:https://openalex.org/W3131528273

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Grant: CNPq-483005/2012-6

FAPESP

Grant: 2018/20403-6

NIH HHS

Grant: K26 OD010945

NCRR NIH HHS

Grant: K26 RR026099

FAPESP

FWCI

1.28

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0344033821000431?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0344033821000431?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.prp.2021.153382

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33647866

Fields of Study

Systemic Sclerosis and Related DiseasesPulmonary Hypertension Research and TreatmentsVasculitis and related conditionsAdultAnimalsCase-Control StudiesCollagen Type VDisease Models, AnimalFemaleHemodynamicsHumansLungMiddle AgedPulmonary ArteryRabbitsScleroderma, SystemicVascular Remodeling

MeSH Terms

AdultAnimalsDisease Models, AnimalFemaleHemodynamicsHumansLungMiddle AgedPulmonary ArteryRabbitsScleroderma, SystemicCase-Control StudiesCollagen Type VVascular Remodeling

Keywords

PathologyPulmonary hypertensionLungPhenocopyBiologyPathogenesisMedicineImmunologyInternal medicinePhenotypeGeneEndotheliumSclerodermaAnimal modelVascular diseaseCollagen V

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer

10.6084/m9.figshare.16835180.v1figshare

Additional file 1 of A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer

10.6084/m9.figshare.16835180figshare